The authors present a review of the literature about the procedure of
stereotactic core breast biopsy. Developed since the beginning of the
1990s, this histopathological sampling technique presents numerous adv
antages. Its low cost, its simplicity and its diagnostic efficacy are
the main arguments for its development. The diagnostic efficacy confir
med on clinical trials (see 2nd part of article) must be preserved if
core biopsy is performed routinely. This means avoiding wrong choices
in indications and respecting evaluated procedures.